Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Correlation of Reactive Oxygen Species Levels with Resveratrol Sensitivities of Anaplastic Thyroid Cancer Cells
Xu Zheng, Bin Jia, Xiaoting Tian, et al.
Oxidative Medicine and Cellular Longevity (2018) Vol. 2018, Iss. 1
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Potential Adverse Effects of Resveratrol: A Literature Review
Abdullah Shaito, Anna Maria Posadino, Nadin Younes, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 6, pp. 2084-2084
Open Access | Times Cited: 504
Health benefits of resveratrol administration
Sabina Galiniak, David Aebisher, Dorota Bartusik‐Aebisher
Acta Biochimica Polonica (2019)
Open Access | Times Cited: 297
Mechanism of Resveratrol-Induced Programmed Cell Death and New Drug Discovery against Cancer: A Review
Jung Yoon Jang, Eunok Im, Nam Deuk Kim
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13689-13689
Open Access | Times Cited: 57
Potential Therapeutic Targets of Resveratrol, a Plant Polyphenol, and Its Role in the Therapy of Various Types of Cancer
Saleh A. Almatroodi, Mohammed A. Alsahli, Abdullah S. M. Aljohani, et al.
Molecules (2022) Vol. 27, Iss. 9, pp. 2665-2665
Open Access | Times Cited: 55
A mechanistic insight into the anticancer potentials of resveratrol: Current perspectives
Md. Shimul Bhuia, Raihan Chowdhury, Mst. Asma Akter, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 8, pp. 3877-3898
Closed Access | Times Cited: 10
Methylglyoxal Acts as a Tumor-Promoting Factor in Anaplastic Thyroid Cancer
Cinzia Antognelli, Sonia Moretti, Roberta Frosini, et al.
Cells (2019) Vol. 8, Iss. 6, pp. 547-547
Open Access | Times Cited: 55
The Role of Resveratrol in Eye Diseases—A Review of the Literature
Anna Bryl, Mariusz Falkowski, Katarzyna Zorena, et al.
Nutrients (2022) Vol. 14, Iss. 14, pp. 2974-2974
Open Access | Times Cited: 33
Natural products and phytochemical nanoformulations targeting mitochondria in oncotherapy: an updated review on resveratrol
Milad Ashrafizadeh, Sara Javanmardi, Masoumeh Moradi-Ozarlou, et al.
Bioscience Reports (2020) Vol. 40, Iss. 4
Open Access | Times Cited: 49
Resveratrol Action on Lipid Metabolism in Cancer
Terézia Kisková, Monika Kassayová
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 11, pp. 2704-2704
Open Access | Times Cited: 44
Studies on the Anticancer and Antioxidant Activities of Resveratrol and Long-Chain Fatty Acid Esters
Patrycja Szczepańska, Magdalena Rychlicka, Sylwia Groborz, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7167-7167
Open Access | Times Cited: 16
Resveratrol combats chronic diseases through enhancing mitochondrial quality
Weichu Tao, Hu Zhang, Xia Jiang, et al.
Deleted Journal (2023) Vol. 13, Iss. 2, pp. 597-610
Open Access | Times Cited: 14
Multimodal and multiscale optical imaging of nanomedicine delivery across the blood-brain barrier upon sonopermeation
Jan‐Niklas May, Susanne K. Golombek, Maike Baues, et al.
Theranostics (2020) Vol. 10, Iss. 4, pp. 1948-1959
Open Access | Times Cited: 38
Targeting the redox imbalance in mitochondria: A novel mode for cancer therapy
Shalini Mani, Geeta Swargiary, Stephen J. Ralph
Mitochondrion (2021) Vol. 62, pp. 50-73
Closed Access | Times Cited: 31
Research progress of SIRTs activator resveratrol and its derivatives in autoimmune diseases
Xiaolong Yu, Mingkai Chen, Jiabiao Wu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Resveratrol Reverses Retinoic Acid Resistance of Anaplastic Thyroid Cancer Cells via Demethylating CRABP2 Gene
Xin Liu, Li Hong, Mo‐Li Wu, et al.
Frontiers in Endocrinology (2019) Vol. 10
Open Access | Times Cited: 34
Resveratrol induces human colorectal cancer cell apoptosis by activating the mitochondrial pathway via increasing reactive oxygen species
Yun Fu, Yuedian Ye, Guifang Zhu, et al.
Molecular Medicine Reports (2020) Vol. 23, Iss. 3
Open Access | Times Cited: 30
Resveratrol and its Nanoparticle suppress Doxorubicin/Docetaxel-resistant anaplastic Thyroid Cancer Cells in vitro and in vivo
Le Xiong, Xiao-Min Lin, Jun‐Hua Nie, et al.
Nanotheranostics (2021) Vol. 5, Iss. 2, pp. 143-154
Open Access | Times Cited: 27
Resveratrol loaded self-nanoemulsifying drug delivery system (SNEDDS) for pancreatic cancer: Formulation design, optimization and in vitro evaluation
Shadab Md, Nabil A. Alhakamy, Hibah M. Aldawsari, et al.
Journal of Drug Delivery Science and Technology (2021) Vol. 64, pp. 102555-102555
Closed Access | Times Cited: 24
Anticancer effects of natural phytochemicals in anaplastic thyroid cancer (Review)
Yitian Li, Jing Zhang, Huihui Zhou, et al.
Oncology Reports (2022) Vol. 48, Iss. 3
Open Access | Times Cited: 17
Historical insights of polyphenols in human health
Javier Quero, Vı́ctor López, Francisco Les, et al.
Elsevier eBooks (2025), pp. 3-42
Closed Access
ZIF-8 nanocarriers synthesized by co-encapsulating resveratrol and cellulase for biomedical applications
Sheik Aliya, Muruganantham Rethinasabapathy, Gothandam Kodiveri Muthukaliannan, et al.
International Journal of Biological Macromolecules (2024) Vol. 283, pp. 137756-137756
Closed Access | Times Cited: 3
Higher efficacy of resveratrol against advanced breast cancer organoids: A comparison with that of clinically relevant drugs
Hai‐Shan Ye, Hongfei Gao, Hong Li, et al.
Phytotherapy Research (2022) Vol. 36, Iss. 8, pp. 3313-3324
Closed Access | Times Cited: 13
Nanomaterials: a promising multimodal theranostics platform for thyroid cancer
Lei Li, Ze Wang, Hui Guo, et al.
Journal of Materials Chemistry B (2023) Vol. 11, Iss. 32, pp. 7544-7566
Closed Access | Times Cited: 8
Dual Inhibition of BRAF-MAPK and STAT3 Signaling Pathways in Resveratrol-Suppressed Anaplastic Thyroid Cancer Cells with BRAF Mutations
Meng‐Di Lu, Hong Li, Jun‐Hua Nie, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14385-14385
Open Access | Times Cited: 12
Promising Approaches in Plant-Based Therapies for Thyroid Cancer: An Overview of In Vitro, In Vivo, and Clinical Trial Studies
Ilona Kaczmarzyk, Martyna Nowak-Perlak, Marta Woźniak
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4463-4463
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top